Brief: Yumanity Therapeutics Announces Effectiveness Of Registration Statement On Form S-4
10/11/2022 21:43
Nov 10 (Reuters) - Yumanity Therapeutics Inc YMTX.O :
* YUMANITY THERAPEUTICS ANNOUNCES EFFECTIVENESS OF
REGISTRATION
STATEMENT ON FORM S-4 IN CONNECTION WITH PROPOSED ASSET SALE TO
JANSSEN AND MERGER WITH KINETA, INC.
Source text for Eikon: ID:nGNX5dLMQn
Further company coverage: YMTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kineta
See all newsBrief: TuHURA Biosciences And Kineta Stockholders Approve Proposed Merger And All Related Proposals
Brief: Kineta Updates KVA12123 Clinical Results From Ongoing Phase 1/2 Vista101 Study At Society For Immunotherapy Of Cancer
U.S. STOCKS ON THE MOVE-Copper miners, Palo Alto Networks, Lowe's
U.S. STOCKS ON THE MOVE-Lineage, J.B. Hunt, McDonald's
Kineta rises on resuming enrollment in early-stage cancer study